NO763980L - - Google Patents

Info

Publication number: NO763980L
Authority: NO; Norway
Prior art keywords: thiazole; group; hydroperoxide; substituted; test strip
Prior art date: 1975-11-21

Application number

NO763980A

Other languages

English (en)

Norwegian (no)

Inventor

Y Ogawa

Y Yonetani

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-11-21

Filing date

1976-11-19

Publication date

1977-05-24

1976-11-19 Application filed by Shionogi & Co filed Critical Shionogi & Co

1977-05-24 Publication of NO763980L publication Critical patent/NO763980L/no

Links

238000012360 testing method Methods 0.000 claims description 59
210000004369 blood Anatomy 0.000 claims description 41
239000008280 blood Substances 0.000 claims description 41
125000000217 alkyl group Chemical group 0.000 claims description 22
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 20
-1 thiazole compound Chemical class 0.000 claims description 15
239000000463 material Substances 0.000 claims description 14
238000000034 method Methods 0.000 claims description 13
239000000243 solution Substances 0.000 claims description 13
229910052739 hydrogen Inorganic materials 0.000 claims description 12
239000001257 hydrogen Substances 0.000 claims description 12
RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 claims description 12
239000003795 chemical substances by application Substances 0.000 claims description 11
230000001235 sensitizing effect Effects 0.000 claims description 11
238000001514 detection method Methods 0.000 claims description 10
239000002250 absorbent Substances 0.000 claims description 9
230000002745 absorbent Effects 0.000 claims description 9
125000003710 aryl alkyl group Chemical group 0.000 claims description 9
LGGRGPPMSNVTCL-UHFFFAOYSA-N 4-methyl-2-(2-phenylethenyl)-1,3-thiazole Chemical compound CC1=CSC(C=CC=2C=CC=CC=2)=N1 LGGRGPPMSNVTCL-UHFFFAOYSA-N 0.000 claims description 8
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
125000004432 carbon atom Chemical group C* 0.000 claims description 8
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 claims description 8
BMPYSUZRFLIYEA-VOTSOKGWSA-N 2-[(e)-2-phenylethenyl]-1,3-thiazole Chemical compound N=1C=CSC=1/C=C/C1=CC=CC=C1 BMPYSUZRFLIYEA-VOTSOKGWSA-N 0.000 claims description 6
OJMYWAMKZDXIMY-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)ethenyl]-1,3-thiazole Chemical compound C1=CC(Cl)=CC=C1C=CC1=NC=CS1 OJMYWAMKZDXIMY-UHFFFAOYSA-N 0.000 claims description 6
SADYIDNQRINMAV-UHFFFAOYSA-N 2-[2-(4-methoxyphenyl)ethenyl]-1,3-thiazole Chemical compound C1=CC(OC)=CC=C1C=CC1=NC=CS1 SADYIDNQRINMAV-UHFFFAOYSA-N 0.000 claims description 6
FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 claims description 6
JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 claims description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
210000001124 body fluid Anatomy 0.000 claims description 6
239000010839 body fluid Substances 0.000 claims description 6
OBSLLHNATPQFMJ-UHFFFAOYSA-N 2,4-Dimethylthiazole Chemical compound CC1=CSC(C)=N1 OBSLLHNATPQFMJ-UHFFFAOYSA-N 0.000 claims description 5
LCIISWPXOZNVIG-UHFFFAOYSA-N 2-(2-phenylethenyl)-1,3-benzothiazole Chemical compound N=1C2=CC=CC=C2SC=1C=CC1=CC=CC=C1 LCIISWPXOZNVIG-UHFFFAOYSA-N 0.000 claims description 5
DFKDQMPZBNLOKK-UHFFFAOYSA-N 2-[2-(4-methoxyphenyl)ethenyl]-4-methyl-1,3-thiazole Chemical compound C1=CC(OC)=CC=C1C=CC1=NC(C)=CS1 DFKDQMPZBNLOKK-UHFFFAOYSA-N 0.000 claims description 5
150000001875 compounds Chemical class 0.000 claims description 5
239000000203 mixture Substances 0.000 claims description 5
YWBMNCRJFZGXJY-UHFFFAOYSA-N 1-hydroperoxy-1,2,3,4-tetrahydronaphthalene Chemical compound C1=CC=C2C(OO)CCCC2=C1 YWBMNCRJFZGXJY-UHFFFAOYSA-N 0.000 claims description 4
JGBAASVQPMTVHO-UHFFFAOYSA-N 2,5-dihydroperoxy-2,5-dimethylhexane Chemical compound OOC(C)(C)CCC(C)(C)OO JGBAASVQPMTVHO-UHFFFAOYSA-N 0.000 claims description 4
YNIWTRIYYTUBSU-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)ethenyl]-1,3-thiazole Chemical compound C1=CC(F)=CC=C1C=CC1=NC=CS1 YNIWTRIYYTUBSU-UHFFFAOYSA-N 0.000 claims description 4
RXKMHYYVMATNGS-UHFFFAOYSA-N 2-[2-(4-methoxyphenyl)ethenyl]-1,3-benzothiazole Chemical compound C1=CC(OC)=CC=C1C=CC1=NC2=CC=CC=C2S1 RXKMHYYVMATNGS-UHFFFAOYSA-N 0.000 claims description 4
COMXWJRXPZDOEE-UHFFFAOYSA-N 2-[2-(4-methylphenyl)ethenyl]-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C=CC1=NC=CS1 COMXWJRXPZDOEE-UHFFFAOYSA-N 0.000 claims description 4
108010010803 Gelatin Proteins 0.000 claims description 4
125000003545 alkoxy group Chemical group 0.000 claims description 4
239000000839 emulsion Substances 0.000 claims description 4
229920000159 gelatin Polymers 0.000 claims description 4
239000008273 gelatin Substances 0.000 claims description 4
235000019322 gelatine Nutrition 0.000 claims description 4
235000011852 gelatine desserts Nutrition 0.000 claims description 4
229910052736 halogen Inorganic materials 0.000 claims description 4
XSZYESUNPWGWFQ-UHFFFAOYSA-N 1-(2-hydroperoxypropan-2-yl)-4-methylcyclohexane Chemical compound CC1CCC(C(C)(C)OO)CC1 XSZYESUNPWGWFQ-UHFFFAOYSA-N 0.000 claims description 3
DWBGHNQQHVVYTD-UHFFFAOYSA-N 2-[2-(4-bromophenyl)ethenyl]-1,3-thiazole Chemical compound C1=CC(Br)=CC=C1C=CC1=NC=CS1 DWBGHNQQHVVYTD-UHFFFAOYSA-N 0.000 claims description 3
VXWKWTVBDTWSCU-UHFFFAOYSA-N 2-[2-(4-ethoxyphenyl)ethenyl]-1,3-thiazole Chemical compound C1=CC(OCC)=CC=C1C=CC1=NC=CS1 VXWKWTVBDTWSCU-UHFFFAOYSA-N 0.000 claims description 3
DZRQEMNTXOKIFR-UHFFFAOYSA-N 4-ethylmorpholine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound CCN1CCOCC1.OC(=O)CC(O)(C(O)=O)CC(O)=O DZRQEMNTXOKIFR-UHFFFAOYSA-N 0.000 claims description 3
241000147041 Guaiacum officinale Species 0.000 claims description 3
229920000084 Gum arabic Polymers 0.000 claims description 3
241000978776 Senegalia senegal Species 0.000 claims description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
239000000205 acacia gum Substances 0.000 claims description 3
235000010489 acacia gum Nutrition 0.000 claims description 3
HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 claims description 3
239000007979 citrate buffer Substances 0.000 claims description 3
SPTHWAJJMLCAQF-UHFFFAOYSA-M ctk4f8481 Chemical compound [O-]O.CC(C)C1=CC=CC=C1C(C)C SPTHWAJJMLCAQF-UHFFFAOYSA-M 0.000 claims description 3
239000000284 extract Substances 0.000 claims description 3
229940091561 guaiac Drugs 0.000 claims description 3
150000002367 halogens Chemical class 0.000 claims description 3
150000002431 hydrogen Chemical class 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims description 3
235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims description 2
RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims 2
XMNIXWIUMCBBBL-UHFFFAOYSA-N 2-(2-phenylpropan-2-ylperoxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OOC(C)(C)C1=CC=CC=C1 XMNIXWIUMCBBBL-UHFFFAOYSA-N 0.000 claims 1
230000001476 alcoholic effect Effects 0.000 claims 1
238000001035 drying Methods 0.000 claims 1
125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
238000004519 manufacturing process Methods 0.000 claims 1
238000006243 chemical reaction Methods 0.000 description 15
230000035945 sensitivity Effects 0.000 description 14
239000000123 paper Substances 0.000 description 11
210000002700 urine Anatomy 0.000 description 11
238000010790 dilution Methods 0.000 description 7
239000012895 dilution Substances 0.000 description 7
238000005470 impregnation Methods 0.000 description 7
230000002949 hemolytic effect Effects 0.000 description 5
210000003608 fece Anatomy 0.000 description 4
208000032843 Hemorrhage Diseases 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
230000000740 bleeding effect Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
150000004680 hydrogen peroxides Chemical class 0.000 description 3
239000000126 substance Substances 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
239000000306 component Substances 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
150000002432 hydroperoxides Chemical class 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
239000000049 pigment Substances 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
150000003557 thiazoles Chemical class 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
MUAWWROODCFBEM-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;morpholine Chemical compound C1COCCN1.OC(=O)CC(O)(C(O)=O)CC(O)=O MUAWWROODCFBEM-UHFFFAOYSA-N 0.000 description 1
VZWOXDYRBDIHMA-UHFFFAOYSA-N 2-methyl-1,3-thiazole Chemical compound CC1=NC=CS1 VZWOXDYRBDIHMA-UHFFFAOYSA-N 0.000 description 1
JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical compound C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
235000001258 Cinchona calisaya Nutrition 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
208000000913 Kidney Calculi Diseases 0.000 description 1
239000002841 Lewis acid Substances 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
206010029148 Nephrolithiasis Diseases 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
206010037549 Purpura Diseases 0.000 description 1
241001672981 Purpura Species 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
238000009534 blood test Methods 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000003183 carcinogenic agent Substances 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
208000028104 epidemic louse-borne typhus Diseases 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000014617 hemorrhoid Diseases 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
239000000644 isotonic solution Substances 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
150000007517 lewis acids Chemical class 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
150000003222 pyridines Chemical class 0.000 description 1
229960000948 quinine Drugs 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000013112 stability test Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
125000005504 styryl group Chemical group 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
239000000725 suspension Substances 0.000 description 1
UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
229960000943 tartrazine Drugs 0.000 description 1
235000012756 tartrazine Nutrition 0.000 description 1
239000004149 tartrazine Substances 0.000 description 1
206010061393 typhus Diseases 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
210000004916 vomit Anatomy 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000002023 wood Substances 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/725—Haemoglobin using peroxidative activity
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/904—Oxidation - reduction indicators

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Wood Science & Technology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cell Biology (AREA)
Biophysics (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO763980A 1975-11-21 1976-11-19 NO763980L (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP50140428A JPS5263794A (en)	1975-11-21	1975-11-21	Test piece for latent blood

Publications (1)

Publication Number	Publication Date
NO763980L true NO763980L (de)	1977-05-24

Family

ID=15268447

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO763980A NO763980L (de)	1975-11-21	1976-11-19

Country Status (14)

Country	Link
US (1)	US4063894A (de)
JP (1)	JPS5263794A (de)
AU (1)	AU504772B2 (de)
BE (1)	BE848564A (de)
CA (1)	CA1067803A (de)
CH (1)	CH623137A5 (de)
DE (1)	DE2652545A1 (de)
DK (1)	DK520576A (de)
ES (1)	ES453442A1 (de)
FR (1)	FR2332534A1 (de)
GB (1)	GB1547846A (de)
NL (1)	NL168050C (de)
NO (1)	NO763980L (de)
SE (1)	SE7612506L (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2716061C2 (de) *	1977-04-09	1982-03-25	Boehringer Mannheim Gmbh, 6800 Mannheim	Guajaconsäure A, Verfahren zu ihrer Herstellung und die Verwendung dieser Substanz als diagnostische Mittel
US4298345A (en)	1977-11-21	1981-11-03	Damon Corporation	Method and apparatus for chemical spot test analysis
DE2854987A1 (de) *	1978-12-20	1980-06-26	Boehringer Mannheim Gmbh	Diagnostische mittel zum nachweis proteolytischer enzyme und dafuer geeignete chromogene
DE2905531A1 (de) *	1979-02-14	1981-01-08	Boehringer Mannheim Gmbh	Diagnostisches mittel zum nachweis von leukozyten in koerperfluessigkeiten
US4277250A (en) *	1979-12-10	1981-07-07	Baylor College Of Medicine	Methods for detecting and quantifying occult blood
US4278439A (en) *	1979-12-17	1981-07-14	Miles Laboratories, Inc.	Sensitizers for peroxidative activity tests
US4251223A (en) *	1979-12-17	1981-02-17	Miles Laboratories, Inc.	Sensitizers for peroxidative activity tests
US4251222A (en) *	1979-12-17	1981-02-17	Miles Laboratories, Inc.	Sensitizers for peroxidative activity tests
US4388271A (en)	1980-01-10	1983-06-14	Rohm Gmbh	Rapid diagnostic agents
FI61965C (fi) *	1980-01-17	1982-10-11	Suovaniemi Finnpipette	Foerfarande foer detektering av hemoglobin i avfoering
US4526869A (en) *	1980-09-24	1985-07-02	Regents Of The University Of Minnesota	Method for quantitatively determining the concentration of hemoglobin in a biological sample
ZA829434B (en) *	1982-01-05	1984-05-30	Hematec Corp	Home diagnostic aid and method for determining the presence of occult blood for use by the general public
US4956300A (en) *	1982-01-05	1990-09-11	Helena Laboratories Corporation	Aid for determining the presence of occult blood, method of making the aid, and method of using the aid
ZA831268B (en) *	1982-04-30	1984-10-31	Hematec Corp	Home diagnostic aid and method for determining the presence of occult blood for use by the general public
US4486536A (en) *	1982-05-28	1984-12-04	Smithkline Diagnostics, Inc.	Specimen slide for occult blood testing
JPS59193352A (ja) *	1983-04-18	1984-11-01	Fuji Photo Film Co Ltd	分析試薬および多層化学分析要素
US5702913A (en) *	1983-12-21	1997-12-30	Helena Laboratories Corporation	Chromgen-reagent test system
US5273888A (en) *	1984-01-16	1993-12-28	Helena Laboratories Corporation	Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals
US4676950A (en) *	1984-02-03	1987-06-30	Foster Research Corporation	Indicator and test device for detecting occult blood
US4939097A (en) *	1986-06-02	1990-07-03	Litmus Concepts, Inc.	Fecal occult blood test methods
US5068197A (en) *	1984-12-11	1991-11-26	Litmus Concepts, Inc.	Fecal occult blood test methods
DE3541979A1 (de) *	1985-11-28	1987-06-04	Behringwerke Ag	Mittel zur bestimmung von peroxidase-aktivitaet mit stabilisator, verfahren zur herstellung und seine verwendung
DE3541978A1 (de) *	1985-11-28	1987-06-04	Behringwerke Ag	Mittel zur bestimmung von peroxidase-aktivitaet, verfahren zur herstellung und seine verwendung
US5081040A (en) *	1987-06-29	1992-01-14	Helena Laboratories Corporation	Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes
US5053342A (en) *	1987-12-24	1991-10-01	Litmus Concepts, Inc.	Fecal occult blood test reagents
US5182191A (en) *	1988-10-14	1993-01-26	Pacific Biotech, Inc.	Occult blood sampling device and assay
US5217874A (en) *	1989-04-04	1993-06-08	Helena Laboratories Corporation	Fecal occult blood test product with positive and negative controls
US5196167A (en) *	1989-04-04	1993-03-23	Helena Laboratories Corporation	Fecal occult blood test product with positive and negative controls
US5447868A (en) *	1993-09-14	1995-09-05	Propper Manufacturing Co. Inc.	Method, reagent and kit for the detection of fecal occult blood
US20030170905A1 (en) *	2002-03-05	2003-09-11	Alexander Kamyshny	Diagnostic beads for the detection of blood in animal excreta and a method for production thereof
US7595196B2 (en) *	2003-09-23	2009-09-29	Oakville Hong Kong Company Limited	Lateral flow assay devices with inhibiting backflow of the sample and methods of use
EP2304437A4 (de) *	2008-07-22	2012-06-20	Siemens Healthcare Diagnostics	Krankheitsspezifische diagnosehilfe
GB0820817D0 (en) *	2008-11-13	2008-12-24	Wireless Biodevices Ltd	Electrode, electrochemical sensor and apparatus, and methods for operating the same
US9091682B1 (en)	2014-05-01	2015-07-28	Steven M Hacker	Tissue specimen bottle with color indicator in lid verifying and confirming presence of human tissue or blood contained in specimen bottle
CN113533704A (zh) *	2021-06-21	2021-10-22	南京市第一医院	一种呕吐物隐血检测装置及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL277911A (de) *	1961-05-04
DE2235127C2 (de) *	1972-07-18	1974-08-08	Boehringer Mannheim Gmbh, 6800 Mannheim	Diagnostisches Mittel zum Nachweis von Blut und anderen peroxidatisch wirksamen Substanzen in Körperflüssigkeiten
CS175782B1 (de) *	1974-10-16	1977-05-31
CS176664B1 (de) *	1975-02-14	1977-06-30
US3986833A (en) *	1975-09-08	1976-10-19	Miles Laboratories, Inc.	Test composition, device, and method for the detection of peroxidatively active substances

1975
- 1975-11-21 JP JP50140428A patent/JPS5263794A/ja active Pending
1976
- 1976-10-12 CA CA263,096A patent/CA1067803A/en not_active Expired
- 1976-10-15 AU AU18752/76A patent/AU504772B2/en not_active Expired
- 1976-10-19 US US05/733,913 patent/US4063894A/en not_active Expired - Lifetime
- 1976-10-22 GB GB44039/76A patent/GB1547846A/en not_active Expired
- 1976-11-10 SE SE7612506A patent/SE7612506L/xx not_active Application Discontinuation
- 1976-11-18 ES ES453442A patent/ES453442A1/es not_active Expired
- 1976-11-18 DE DE19762652545 patent/DE2652545A1/de not_active Withdrawn
- 1976-11-18 FR FR7634771A patent/FR2332534A1/fr active Granted
- 1976-11-18 DK DK520576A patent/DK520576A/da not_active Application Discontinuation
- 1976-11-19 NO NO763980A patent/NO763980L/no unknown
- 1976-11-19 BE BE172544A patent/BE848564A/xx unknown
- 1976-11-22 NL NL7612999A patent/NL168050C/xx not_active IP Right Cessation
- 1976-11-22 CH CH1465976A patent/CH623137A5/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
NL168050B (nl)	1981-09-16
FR2332534B1 (de)	1981-05-22
CA1067803A (en)	1979-12-11
US4063894A (en)	1977-12-20
AU504772B2 (en)	1979-10-25
NL7612999A (nl)	1977-05-24
JPS5263794A (en)	1977-05-26
GB1547846A (en)	1979-06-27
SE7612506L (sv)	1977-05-22
AU1875276A (en)	1978-04-20
NL168050C (nl)	1982-02-16
DE2652545A1 (de)	1977-05-26
DK520576A (da)	1977-05-22
FR2332534A1 (fr)	1977-06-17
ES453442A1 (es)	1977-11-16
BE848564A (fr)	1977-03-16
CH623137A5 (de)	1981-05-15

Publication	Publication Date	Title
NO763980L (de)	1977-05-24
TW508436B (en)	2002-11-01	Stable coupling dye for photometric determination of analytes
US3917452A (en)	1975-11-04	Diagnostic agent for the detection of peroxidatively active substances
DK159171B (da)	1990-09-10	Materiale til detektering af naervaerelsen af et peroxidativt aktivt stof i en testproeve, testmiddel indeholdende materialet samt fremgangsmaade til fremstilling af testmidlet.
US4957872A (en)	1990-09-18	Method for the determination of redox reactions using iodate to eliminate asorbic acid interference
JPS5831873B2 (ja)	1983-07-08	過酸化的活性物質と検出するための試験用組成物
JPS6075299A (ja)	1985-04-27	エタノ−ル測色分析法およびその試験用製品
NO852070L (no)	1985-12-05	Enzymatisk etanolpaavisning.
US4273868A (en)	1981-06-16	Color stable glucose test
JPH04237500A (ja)	1992-08-25	ケトン体の検定のための組成物及び方法
US3630847A (en)	1971-12-28	Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances
JPS5819989B2 (ja)	1983-04-21	過酸化物測定用試験組成物
JPH066073B2 (ja)	1994-01-26	ヘモグロビンのペルオキシダ−ゼ様活性測定のための組成物および方法
US4291121A (en)	1981-09-22	Bilirubin-resistant determination of uric acid and cholesterol
DK143147B (da)	1981-06-29	Fremgangsmaade til paavisning af urobilinogen eventuelt sammen med bilirubin samt middel til brug ved fremgangsmaaden
FI93277B (fi)	1994-11-30	Testikoostumus ja -väline vetyperoksidin määrittämiseksi visuaalisesti
US4132527A (en)	1979-01-02	Diagnostic compositions, diagnosing instruments, and methods of manufacturing same
AU646525B2 (en)	1994-02-24	Peroxidase indicator system for basic media
CN105699640B (zh)	2017-06-06	一种检测肠道屏障功能的试剂盒
DK153334B (da)	1988-07-04	Diagnostiske praeparater
US4481295A (en)	1984-11-06	Substituted or condensed pyridines in a process for the detection of substances having a peroxidatic effect and a diagnostic agent containing such pyridines
JP5938713B2 (ja)	2016-06-22	ヘモグロビンの高感度測定法と試薬
KR800001002B1 (ko)	1980-09-19	잠혈용시험편
JP3289131B2 (ja)	2002-06-04	酸化還元反応に基づくｐｏｄ様活性物質測定用組成物
JPH0770462A (ja)	1995-03-14	水溶性メチレンビスジアルキルアニリン誘導体及びその塩類並びにそれらを用いた過酸化物質定量用組成物